Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

EXAI

Exscientia (EXAI)

Exscientia PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:EXAI
DateTimeSourceHeadlineSymbolCompany
03/12/202400:39Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:EXAIExscientia PLC
23/11/202412:00Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:EXAIExscientia PLC
21/11/202402:01Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:EXAIExscientia PLC
21/11/202401:53Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:EXAIExscientia PLC
21/11/202401:20Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EXAIExscientia PLC
20/11/202423:00GlobeNewswire Inc.Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discoveryNASDAQ:EXAIExscientia PLC
14/11/202402:37Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EXAIExscientia PLC
13/11/202408:55Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EXAIExscientia PLC
08/11/202422:40Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EXAIExscientia PLC
06/11/202422:08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EXAIExscientia PLC
25/10/202407:00Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXAIExscientia PLC
17/10/202412:49Business WireExscientia franchit des étapes importantes pour deux de ses programmes dans le cadre de sa collaboration avec SanofiNASDAQ:EXAIExscientia PLC
17/10/202412:35Business WireExscientia erreicht Meilensteine ​​für zwei Programme im Rahmen der Zusammenarbeit mit SanofiNASDAQ:EXAIExscientia PLC
16/10/202422:00Business WireExscientia Achieves Milestones for Two Programmes in Sanofi CollaborationNASDAQ:EXAIExscientia PLC
10/10/202421:04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EXAIExscientia PLC
10/10/202406:25Business WireExscientia präsentiert auf der ENA 2024 neue präklinische Daten für KI-gestützte LSD1- und MALT1-InhibitorenNASDAQ:EXAIExscientia PLC
10/10/202406:25Business WireExscientia présentera de nouvelles données précliniques pour les inhibiteurs de la LSD1 et du MALT1 conçus par l'IA à l'ENA 2024NASDAQ:EXAIExscientia PLC
09/10/202422:00Business WireExscientia to Present New Preclinical Data for AI-designed LSD1 and MALT1 Inhibitors at ENA 2024NASDAQ:EXAIExscientia PLC
30/08/202422:57Edgar (US Regulatory)Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]NASDAQ:EXAIExscientia PLC
29/08/202406:42Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EXAIExscientia PLC
29/08/202402:11Business WireExscientia wird auf der 22nd Annual Global Healthcare Conference Präsentation durchführenNASDAQ:EXAIExscientia PLC
29/08/202402:11Business WireExscientia participera à la 22e conférence annuelle de Morgan Stanley sur les soins médicaux dans le mondeNASDAQ:EXAIExscientia PLC
28/08/202421:00Business WireExscientia to Present at the Morgan Stanley 22nd Annual Global Healthcare ConferenceNASDAQ:EXAIExscientia PLC
24/08/202406:07Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXAIExscientia PLC
15/08/202421:19Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EXAIExscientia PLC
15/08/202421:00Business WireExscientia Business Update for Second Quarter and First Half 2024NASDAQ:EXAIExscientia PLC
09/08/202419:44IH Market NewsTSMC July Revenue Surges 45%, Nasdaq Accelerates Penny Stock Delistings, Moody’s Downgrades Intel to BAA1, and MoreNASDAQ:EXAIExscientia PLC
09/08/202407:19Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EXAIExscientia PLC
08/08/202421:39GlobeNewswire Inc.Recursion and Exscientia Enter Definitive Agreement to Create a Global Technology-Enabled Drug Discovery Leader with End-to-End CapabilitiesNASDAQ:EXAIExscientia PLC
25/07/202406:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXAIExscientia PLC
 Showing the most relevant articles for your search:NASDAQ:EXAI